Methodology

Second Look Cancer is designed to help colorectal cancer patients and caregivers review public clinical trial information with more context than a raw registry search alone provides.

Our job is to organize, summarize, and clarify public trial information so users can decide what deserves a closer look with their care team and with trial-site staff.

The platform ingests or references public trial records, normalizes common fields, groups locations, maps biomarkers and treatment categories where possible, and presents records in patient-facing formats.

Summaries, filters, labels, and explanations are intended to make source material easier to review. They may simplify, reformat, or classify public information, and they should be checked against original sources before use.

Matching and ranking are relevance tools. They use information a user provides, such as diagnosis context, biomarkers, treatment history, and geography, to surface trials that may be worth discussing.

A match, shortlist, score, or summary is not a medical recommendation, suitability determination, eligibility decision, enrollment decision, or guarantee that a site is accepting a particular patient.

Educational and trust content is reviewed for accuracy, clarity, patient readability, and consistency with the site's informational-tool posture before publication or major revision.

When trial-facing pages are updated, we prioritize alignment with accessible source material, especially official registry records, while acknowledging that public data can lag behind real-world site availability.

Clinical trial records may be incomplete, delayed, inconsistent across sources, or hard to interpret. Public sponsor or conference materials may also be selective, preliminary, or superseded by later updates.

Users should confirm status, eligibility criteria, logistics, costs, contacts, and medical relevance with the official record, the study site or sponsor, and their oncology team before taking action.